Postpartum thyroiditis epidemiology and demographics: Difference between revisions
Sunny Kumar (talk | contribs) |
Usama Talib (talk | contribs) No edit summary |
||
(16 intermediate revisions by 3 users not shown) | |||
Line 2: | Line 2: | ||
{{Postpartum thyroiditis}} | {{Postpartum thyroiditis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{SKA}} | ||
==Overview== | ==Overview== | ||
In 2012, the [[incidence]] of [[Postpartum thyroiditis|postpartum thyroiditis "PPT"]] was estimated to be 1600 to 18200 cases per 100,000 women. [[Incidence]] of [[Postpartum thyroiditis|PPT]] increase in patients with [[Diabetes mellitus type 1|type 1 DM]] up to 25000 per 100,000 women. In 2012, the prevalence of PPT was estimated to be from 1000 to 20000, with a mean prevalence of 5000 cases per 100,000 women. PPT occurs in women of child bearing age. [[Postpartum thyroiditis|PPT]] usually affects individuals of the Mediterranean and Caucasian population race. Mongolian race is usually less affected with PPT. The majority of [[Postpartum thyroiditis|PPT]] cases are reported in Europe and Japan. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
The epidemiology and demographics of postpartum thyroiditis is as follows:<ref name="pmid10447018">{{cite journal| author=Amino N, Tada H, Hidaka Y| title=Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease. | journal=Thyroid | year= 1999 | volume= 9 | issue= 7 | pages= 705-13 | pmid=10447018 | doi=10.1089/thy.1999.9.705 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10447018 }}</ref><ref name="pmid1525572">{{cite journal| author=Lazarus JH| title=Postpartum thyroid dysfunction. | journal=Thyroid | year= 1992 | volume= 2 | issue= 1 | pages= 81 | pmid=1525572 | doi=10.1089/thy.1992.2.81 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1525572 }}</ref> | |||
===Incidence=== | ===Incidence=== | ||
* | *In 2012, the [[incidence]] of [[Postpartum thyroiditis|PPT]] was estimated to be 1600 to 18200 cases per 100,000 women. | ||
* | *[[Incidence]] of [[Postpartum thyroiditis|PPT]] increase with patients having type 1 [[DM]] up to 25000 per 100,000 women. | ||
*[[Incidence]] of [[Postpartum thyroiditis|PPT]] increase with subsequent pregnancies. | |||
*[[Incidence]] of [[Postpartum thyroiditis|PPT]] increase with postive [[Thyroid peroxidase|TPO]] [[antibodies]] and subsequent pregnancies to approximately 70000 cases per 100,000 women. | |||
*In 2000, the [[incidence]] of [[Postpartum thyroiditis|PPT]] was established to be approximately 7800 cases per 100,000 Mediterranean population. | |||
===Prevalence=== | ===Prevalence=== | ||
*In 2012, the [[prevalence]] of [[Postpartum thyroiditis|PPT]] was estimated to be from 1000 to 20000, with a mean [[prevalence]] of 5000 cases per 100,000 women. | |||
*In | |||
===Case-fatality rate=== | ===Case-fatality rate=== | ||
* | *There is no data to suggest the case fatality rate of postpartum thyroiditis. | ||
===Age=== | ===Age=== | ||
* | *[[Postpartum thyroiditis|PPT]] occurs in women in child bearing age. | ||
===Race=== | ===Race=== | ||
* | *[[Postpartum thyroiditis|PPT]] usually affects individuals of the Mediterranean and Caucasians population race. | ||
*Mongolian race is usually less effected. | |||
* | |||
===Region=== | ===Region=== | ||
*The majority of [ | *The majority of [[Postpartum thyroiditis|PPT]] cases are reported in Europe and Japan. | ||
===Developed Countries=== | ===Developed Countries=== | ||
*In USA, 9000 cases per 100,000 women have been reported to have [[Postpartum thyroiditis|PPT]]. | |||
*In Britain, 16700 cases per 100,000 women have been reported to have [[Postpartum thyroiditis|PPT]]. | |||
*In Italy, 8700 cases per 100,000 women have been reported to have [[Postpartum thyroiditis|PPT]]. | |||
===Developing Countries=== | ===Developing Countries=== | ||
*In India, 7000 cases per 100,000 women have been reported to have [[Postpartum thyroiditis|PPT]]. | |||
*In Japan, 5300 to 21000 cases per 100,000 women have been reported to have [[Postpartum thyroiditis|PPT]]. | |||
*In Thailand, 1100 cases per 100,000 women have been reported to have [[Postpartum thyroiditis|PPT]]. | |||
==References== | ==References== | ||
Line 47: | Line 45: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 14:54, 10 November 2017
Postpartum thyroiditis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Postpartum thyroiditis epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Postpartum thyroiditis epidemiology and demographics |
Postpartum thyroiditis epidemiology and demographics in the news |
Blogs on Postpartum thyroiditis epidemiology and demographics |
Risk calculators and risk factors for Postpartum thyroiditis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sunny Kumar MD [2]
Overview
In 2012, the incidence of postpartum thyroiditis "PPT" was estimated to be 1600 to 18200 cases per 100,000 women. Incidence of PPT increase in patients with type 1 DM up to 25000 per 100,000 women. In 2012, the prevalence of PPT was estimated to be from 1000 to 20000, with a mean prevalence of 5000 cases per 100,000 women. PPT occurs in women of child bearing age. PPT usually affects individuals of the Mediterranean and Caucasian population race. Mongolian race is usually less affected with PPT. The majority of PPT cases are reported in Europe and Japan.
Epidemiology and Demographics
The epidemiology and demographics of postpartum thyroiditis is as follows:[1][2]
Incidence
- In 2012, the incidence of PPT was estimated to be 1600 to 18200 cases per 100,000 women.
- Incidence of PPT increase with patients having type 1 DM up to 25000 per 100,000 women.
- Incidence of PPT increase with subsequent pregnancies.
- Incidence of PPT increase with postive TPO antibodies and subsequent pregnancies to approximately 70000 cases per 100,000 women.
- In 2000, the incidence of PPT was established to be approximately 7800 cases per 100,000 Mediterranean population.
Prevalence
- In 2012, the prevalence of PPT was estimated to be from 1000 to 20000, with a mean prevalence of 5000 cases per 100,000 women.
Case-fatality rate
- There is no data to suggest the case fatality rate of postpartum thyroiditis.
Age
- PPT occurs in women in child bearing age.
Race
- PPT usually affects individuals of the Mediterranean and Caucasians population race.
- Mongolian race is usually less effected.
Region
- The majority of PPT cases are reported in Europe and Japan.
Developed Countries
- In USA, 9000 cases per 100,000 women have been reported to have PPT.
- In Britain, 16700 cases per 100,000 women have been reported to have PPT.
- In Italy, 8700 cases per 100,000 women have been reported to have PPT.
Developing Countries
- In India, 7000 cases per 100,000 women have been reported to have PPT.
- In Japan, 5300 to 21000 cases per 100,000 women have been reported to have PPT.
- In Thailand, 1100 cases per 100,000 women have been reported to have PPT.
References
- ↑ Amino N, Tada H, Hidaka Y (1999). "Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease". Thyroid. 9 (7): 705–13. doi:10.1089/thy.1999.9.705. PMID 10447018.
- ↑ Lazarus JH (1992). "Postpartum thyroid dysfunction". Thyroid. 2 (1): 81. doi:10.1089/thy.1992.2.81. PMID 1525572.